356 related articles for article (PubMed ID: 24796722)
1. Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations.
Goto M; Saito Y; Honda R; Saito T; Sugai K; Matsuda Y; Miyatake C; Takeshita E; Ishiyama A; Komaki H; Nakagawa E; Sasaki M; Uto C; Kikuchi K; Motoki T; Saitoh S
Brain Dev; 2015 Feb; 37(2):216-22. PubMed ID: 24796722
[TBL] [Abstract][Full Text] [Related]
2. Myoclonus in Angelman syndrome.
Pollack SF; Grocott OR; Parkin KA; Larson AM; Thibert RL
Epilepsy Behav; 2018 May; 82():170-174. PubMed ID: 29555100
[TBL] [Abstract][Full Text] [Related]
3. Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling.
Moncla A; Malzac P; Livet MO; Voelckel MA; Mancini J; Delaroziere JC; Philip N; Mattei JF
J Med Genet; 1999 Jul; 36(7):554-60. PubMed ID: 10424818
[TBL] [Abstract][Full Text] [Related]
4. Angelman Syndrome Due to UBE3A Gene Mutation.
Goswami JN; Sahu JK; Singhi P
Indian J Pediatr; 2018 May; 85(5):390-391. PubMed ID: 29250725
[TBL] [Abstract][Full Text] [Related]
5. Myoclonic status and central fever in Angelman syndrome due to paternal uniparental disomy.
Nicita F; Garone G; Papetti L; Consoli F; Magliozzi M; De Luca A; Spalice A
J Neurogenet; 2015; 29(4):178-82. PubMed ID: 26559560
[TBL] [Abstract][Full Text] [Related]
6. Cortical myoclonus in Angelman syndrome.
Guerrini R; De Lorey TM; Bonanni P; Moncla A; Dravet C; Suisse G; Livet MO; Bureau M; Malzac P; Genton P; Thomas P; Sartucci F; Simi P; Serratosa JM
Ann Neurol; 1996 Jul; 40(1):39-48. PubMed ID: 8687190
[TBL] [Abstract][Full Text] [Related]
7. Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.
Guerrini R; Carrozzo R; Rinaldi R; Bonanni P
Paediatr Drugs; 2003; 5(10):647-61. PubMed ID: 14510623
[TBL] [Abstract][Full Text] [Related]
8. Parental imprinting and Angelman syndrome.
Lalande M; Minassian BA; DeLorey TM; Olsen RW
Adv Neurol; 1999; 79():421-9. PubMed ID: 10514831
[TBL] [Abstract][Full Text] [Related]
9. Epilepsy in Angelman syndrome: A scoping review.
Samanta D
Brain Dev; 2021 Jan; 43(1):32-44. PubMed ID: 32893075
[TBL] [Abstract][Full Text] [Related]
10. Screening of UBE3A gene in patients referred for Angelman Syndrome.
Tzagkaraki E; Sofocleous C; Fryssira-Kanioura H; Dinopoulos A; Goulielmos G; Mavrou A; Kitsiou-Tzeli S; Kanavakis E
Eur J Paediatr Neurol; 2013 Jul; 17(4):366-73. PubMed ID: 23416059
[TBL] [Abstract][Full Text] [Related]
11. Implications of slow waves and shifting epileptiform discharges in Angelman syndrome.
Yum MS; Lee EH; Kim JH; Ko TS; Yoo HW
Brain Dev; 2013 Mar; 35(3):245-51. PubMed ID: 22704603
[TBL] [Abstract][Full Text] [Related]
12. Atypical absences and recurrent absence status in an adult with Angelman syndrome due to the UBE3A mutation.
Espay AJ; Andrade DM; Wennberg RA; Lang AE
Epileptic Disord; 2005 Sep; 7(3):227-30. PubMed ID: 16162432
[TBL] [Abstract][Full Text] [Related]
13. Angelman syndrome due to a termination codon mutation of the UBE3A gene.
Al-Maawali A; Machado J; Fang P; Dupuis L; Faghfoury H; Mendoza-Londono R
J Child Neurol; 2013 Mar; 28(3):392-5. PubMed ID: 22566713
[TBL] [Abstract][Full Text] [Related]
14. Angelman syndrome: correlations between epilepsy phenotypes and genotypes.
Minassian BA; DeLorey TM; Olsen RW; Philippart M; Bronstein Y; Zhang Q; Guerrini R; Van Ness P; Livet MO; Delgado-Escueta AV
Ann Neurol; 1998 Apr; 43(4):485-93. PubMed ID: 9546330
[TBL] [Abstract][Full Text] [Related]
15. Novel human pathological mutations. Gene symbol: UBE3A. Disease: Angelman Syndrome.
Tzagkaraki E; Christalena S; Helen F; Argyris D; Ariadni M; Emmanuel K
Hum Genet; 2009 Aug; 126(2):331. PubMed ID: 19693993
[No Abstract] [Full Text] [Related]
16. From electrophysiology to chromatin: a bottom-up approach to Angelman syndrome.
Dan B; Servais L; Boyd SG; Wagstaff J; Cheron G
Ann N Y Acad Sci; 2004 Dec; 1030():599-611. PubMed ID: 15659843
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical characterization of Angelman syndrome in Chinese patients.
Bai JL; Qu YJ; Jin YW; Wang H; Yang YL; Jiang YW; Yang XY; Zou LP; Song F
Clin Genet; 2014 Mar; 85(3):273-7. PubMed ID: 23551092
[TBL] [Abstract][Full Text] [Related]
18. Mutation Update for UBE3A variants in Angelman syndrome.
Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
[TBL] [Abstract][Full Text] [Related]
19. Electroclinical characteristics of seizures-comparing Prader--Willi syndrome with Angelman syndrome.
Wang PJ; Hou JW; Sue WC; Lee WT
Brain Dev; 2005 Mar; 27(2):101-7. PubMed ID: 15668048
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R
Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
